Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Comai

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|October 8, 2025
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled TrialClotilde Guidetti, George I Papakostas, Luca Pani, et al.
British Journal of Pharmacology|October 31, 2022
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiomeAntonio Inserra, Giada Giorgini, Sebastien Lacroix, et al.
Journal of Neuro-Oncology|July 28, 2025
Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective studyFilippo Gagliardi, Francesca Roncelli, Silvia Snider, et al.
Pain|January 20, 2015
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha Lopez-Canul, Enza Palazzo, Sergio Dominguez-Lopez, et al.
Biomedicines|November 27, 2021
Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeManuela Simonato, Stefano Dall'Acqua, Caterina Zilli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmissionDanilo De Gregorio, Jelena Popic, Justine P Enns, et al.
Schizophrenia Research. Cognition|September 16, 2024
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exerciseJacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Brain Sciences|May 16, 2023
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary AnalysisPasquale Paribello, Alessio Squassina, Claudia Pisanu, et al.
Nature Communications|June 27, 2018
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4EArgel Aguilar-Valles, Nabila Haji, Danilo De Gregorio, et al.
Metabolites|November 24, 2022
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar DisorderClaudia Pisanu, Alessio Squassina, Pasquale Paribello, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|October 8, 2025
Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Antidepressant Tachyphylaxis: An Exploratory Post Hoc Analysis From a Phase 3 Randomized Controlled TrialClotilde Guidetti, George I Papakostas, Luca Pani, et al.
British Journal of Pharmacology|October 31, 2022
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiomeAntonio Inserra, Giada Giorgini, Sebastien Lacroix, et al.
Journal of Neuro-Oncology|July 28, 2025
Circulating levels of glutamate predict brain disease in patients with advanced lung and breast cancer: a prospective studyFilippo Gagliardi, Francesca Roncelli, Silvia Snider, et al.
Pain|January 20, 2015
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha Lopez-Canul, Enza Palazzo, Sergio Dominguez-Lopez, et al.
Biomedicines|November 27, 2021
Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue SyndromeManuela Simonato, Stefano Dall'Acqua, Caterina Zilli, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmissionDanilo De Gregorio, Jelena Popic, Justine P Enns, et al.
Schizophrenia Research. Cognition|September 16, 2024
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exerciseJacopo Sapienza, Giulia Agostoni, Stefano Comai, et al.
Brain Sciences|May 16, 2023
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary AnalysisPasquale Paribello, Alessio Squassina, Claudia Pisanu, et al.
Nature Communications|June 27, 2018
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4EArgel Aguilar-Valles, Nabila Haji, Danilo De Gregorio, et al.
Metabolites|November 24, 2022
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar DisorderClaudia Pisanu, Alessio Squassina, Pasquale Paribello, et al.
Pageof 13